Alphabet-A
GOOGL
Alphabet-C
GOOG
MicroStrategy
MSTR
Tesla
TSLA
Ecopetrol
EC
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 24.810
- +0.550+2.27%
Close Dec 10 16:00 ET
- 24.340
- -0.470-1.89%
Pre 04:26 ET
734.30MMarket Cap-10.86P/E (TTM)
25.350High23.810Low160.17KVolume24.260Open24.260Pre Close3.96MTurnover1.28%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High2.17P/B309.42MFloat Cap6.58052wk Low--Dividend TTM12.47MShs Float336.000Historical High--Div YieldTTM6.35%Amplitude5.136Historical Low24.746Avg Price1Lot Size
About Dianthus Therapeutics Company
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Company Profile
SymbolDNTH
Company NameDianthus Therapeutics
Listing DateJun 21, 2018
Founded2015
CEOMr. Marino Garcia
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address7 Times Square,43rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-929-999-4055
Websitehttp://dianthustx.com
Company Executives
- Name
- Position
- Salary
- Marino Garcia
- President, Chief Executive Officer and Director
- --
- Dr. Simrat Randhawa, M.D.
- Chief Medical Officer
- --
- Ryan Savitz
- Chief Financial Officer, Chief Business Officer and Treasurer
- --
- Edward G. Carr
- Chief Accounting Officer
- --
- Adam M. Veness
- Senior Vice President, General Counsel and Secretary
- --
- Leon O. Moulder, Jr
- Chairman of the Board
- --
- Dr. Steven Joseph Romano, M.D.
- Director
- --
- Dr. Jonathan Violin, M.B.A.,PhD
- Director
- --
- Paula Soteropoulos
- Independent Director
- --
- Anne M. McGeorge
- Independent Director
- --
- Alison F. Lawton
- Independent Director
- --
- Tomas Kiselak
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.